MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jpedsurg.2025.162324

Медицинская библиотека · Journal of pediatric surgery · 2025

Impact of Immunosuppression on Complication Rates in Pediatric Gastrostomy Tube Placement.

Longi Faraz N, Carter Michela, Reiter Audra J, Patel Lav, Raval Mehul V, Lautz Timothy B

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Immunosuppressed children are vulnerable to post-operative complications. The purpose of this study is to determine if children who are immunosuppressed at gastrostomy tube (G-tube) placement experience higher rates of post-operative complications than children with normal immune function.

METHODS

Children ≤18 years-old who underwent G-tube placement at a high-volume tertiary children's hospital between June 2019-April 2022 were retrospectively identified. Patients who received chemotherapy or post-transplantation immunosuppressive therapy ≤3 months before or 30 days after G-tube placement were identified as the immunosuppressed cohort and 30-day postoperative complication rates were compared. Subset analysis was performed for immunosuppressed children who were neutropenic in the perioperative period.

RESULTS

Thirty-one (5.6 %) of 553 children who underwent G-tube placement were immunosuppressed. Immunosuppressed patients were older (median [IQR] 48 [19-156] months vs. 9 [4-31] months, p < 0.001). The majority underwent laparoscopic placement (71.1 %). There were significantly more PEG placements in the immunosuppressed cohort (22.6 % vs. 4.4 %, p < 0.001). There was no difference in 30-day complication rate between the immunosuppressed and immunocompetent cohorts (29.0 % vs. 34.5 %, p = 0.53); however, there was a higher rate of return to OR for the immunosuppressed cohort (9.7 % vs. 2.7 %, p = 0.03). Subset analysis of the high-risk neutropenic subgroup (n = 13, 41.9 %) revealed no difference in complication rates compared to the non-neutropenic immunosuppressed subgroup.

CONCLUSION

G-tube placement in immunosuppressed patients, including those with perioperative neutropenia, appears to be safe with a comparable safety profile to G-tube placement in children with normal immune function, with the exception of a higher rate of return to the OR within 30 days.

STUDY TYPE: Treatment study.

LEVEL OF EVIDENCE: Level III.

Для цитирования: Longi Faraz N, Carter Michela, Reiter Audra J, Patel Lav, Raval Mehul V, Lautz Timothy B. Impact of Immunosuppression on Complication Rates in Pediatric Gastrostomy Tube Placement.. Journal of pediatric surgery. 2025. DOI: 10.1016/j.jpedsurg.2025.162324.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.